The European Healthcare Technology (HealthTech), Medical Technology (MedTech), and Healthcare Artificial Intelligence (AI) sectors have entered a period of structural realignment following the end of the Zero Interest Rate Policy (ZIRP) era. Enterprise valuations across the digital health ecosystem are no longer driven by speculative top-line revenue growth. Instead, modern valuation models prioritise capital efficiency, demonstrated unit economics, verifiable clinical utili